Wakamatsu, K.; Chiba, Y.; Murakami, R.; Miyai, Y.; Matsumoto, K.; Kamada, M.; Nonaka, W.; Uemura, N.; Yanase, K.; Ueno, M.
Metabolites and Biomarker Compounds of Neurodegenerative Diseases in Cerebrospinal Fluid. Metabolites 2022, 12, 343.
https://doi.org/10.3390/metabo12040343
AMA Style
Wakamatsu K, Chiba Y, Murakami R, Miyai Y, Matsumoto K, Kamada M, Nonaka W, Uemura N, Yanase K, Ueno M.
Metabolites and Biomarker Compounds of Neurodegenerative Diseases in Cerebrospinal Fluid. Metabolites. 2022; 12(4):343.
https://doi.org/10.3390/metabo12040343
Chicago/Turabian Style
Wakamatsu, Keiji, Yoichi Chiba, Ryuta Murakami, Yumi Miyai, Koichi Matsumoto, Masaki Kamada, Wakako Nonaka, Naoya Uemura, Ken Yanase, and Masaki Ueno.
2022. "Metabolites and Biomarker Compounds of Neurodegenerative Diseases in Cerebrospinal Fluid" Metabolites 12, no. 4: 343.
https://doi.org/10.3390/metabo12040343
APA Style
Wakamatsu, K., Chiba, Y., Murakami, R., Miyai, Y., Matsumoto, K., Kamada, M., Nonaka, W., Uemura, N., Yanase, K., & Ueno, M.
(2022). Metabolites and Biomarker Compounds of Neurodegenerative Diseases in Cerebrospinal Fluid. Metabolites, 12(4), 343.
https://doi.org/10.3390/metabo12040343
